SCHEMBL7209964

SCHEMBL7209964

CC=CC1c2cc(OC)ccc2OCc2ncccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36
HTR2B P41595 2/20 0.35
SIGMAR1 Q99720 2/20 0.35
HTR1A P08908 2/20 0.35
ALDH1A1 P00352 5/20 0.34
MAPT P10636 4/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ALOX12 P18054 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR7 P34969 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
CYP19A1 P11511 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10699642 0.82 EDNRB (0.41) EDNRBEDNRAHTR2BSIGMAR1HTR1A
SCHEMBL10702160 0.81 HTR2B (0.40) EDNRBEDNRAHTR2BSIGMAR1HTR1A
SCHEMBL8800043 0.78 DRD2 (0.36) EDNRBEDNRAHTR2BSIGMAR1HTR1A
SCHEMBL8797672 0.77 EDNRB (0.46) EDNRBEDNRAALDH1A1MAPTGAA
SCHEMBL7615965 0.75 HTR1A (0.35) EDNRBEDNRAHTR2BSIGMAR1HTR1A
SCHEMBL12121841 0.71 MAPT (0.50) ALDH1A1MAPTGAAHPGDTDP1
SCHEMBL8797372 0.70 LPAR1 (0.45) EDNRBEDNRAALDH1A1MAPTHPGD
Fumaric Acid SCHEMBL29896602 0.68 CYP1A2 (0.36) EDNRBEDNRAALDH1A1MAPTGAA
SCHEMBL654200 0.68 MAPT (0.49) EDNRBEDNRAALDH1A1MAPTGAA
SCHEMBL654789 0.68 ALDH1A1 (0.66) ALDH1A1MAPTGAAHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613905-B1 Treating or preventing a disease associated with aberrant leukocyte recruitment and/or activation MILLENNIUM PHARMACEUTICALS, INC. 2003-09-02 US disclosed